Fri Sep 20 06:00:00 UTC 2024: ## COVID-19 Vaccine Linked to New-Onset Psychosis in 18-Year-Old, Raising Concerns About Neurological Side Effects

**[City, State] -** A recent case study published in *Schizophrenia Research* has raised concerns about potential neurological side effects of the COVID-19 vaccine. The study details the case of an 18-year-old female student who developed new-onset psychosis after receiving the Covishield vaccine, a version of the AstraZeneca vaccine manufactured in India.

Prior to vaccination, the student had no history of mental or physical illness, highlighting the potential for the vaccine to trigger unexpected neurological issues. The study notes that while research on COVID-19 vaccine side effects often focuses on physical ailments like headaches, seizures, and paralysis, this case demonstrates a possible link to psychiatric complications.

The researchers acknowledge the limited data available on the psychiatric effects of COVID-19 vaccines. However, they emphasize the importance of continued monitoring and surveillance of vaccinated individuals, especially in light of the significant occurrence of neurological complications observed in this and other studies.

This case study also highlights the need for further investigation into the potential connection between vaccines and autoimmune encephalitis, a condition that causes brain swelling and can manifest as psychosis.

While the study underscores the potential for rare neurological complications, it is essential to note that the vast majority of individuals who receive COVID-19 vaccines experience no serious side effects. However, this case, along with other emerging research, demonstrates the importance of ongoing vigilance and data collection to better understand the full range of possible vaccine side effects.

Read More